TABLE 1. GLOBAL ANTIFUNGAL DRUGS MARKET, BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 2. GLOBAL SUPERFICIAL ANTIFUNGAL INFECTION MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL SYSTEMIC ANTIFUNGAL INFECTION MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL ANTIFUNGAL DRUGS MARKET, BY DRUG TYPE, 2016-2023 ($MILLION)
TABLE 5. GLOBAL ANTIFUNGAL DRUGS MARKET FOR ECHINOCANDINS, BY TYPE, 2016-2023 ($MILLION)
TABLE 6. GLOBAL ANTIFUNGAL DRUGS MARKET FOR ECHINOCANDINS, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL ECHINOCANDINS ANTIFUNGAL DRUGS MARKET FOR MICAFUNGIN, BY REGION, 2016-2023 ($MILLION)
TABLE 8. GLOBAL ECHINOCANDINS ANTIFUNGAL DRUGS MARKET FOR CASPOFUNGIN, BY REGION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL ECHINOCANDINS ANTIFUNGAL DRUGS MARKET FOR ANIDULAFUNGIN, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL ECHINOCANDINS ANTIFUNGAL DRUGS MARKET FOR OTHER DRUGS, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL ANTIFUNGAL DRUGS MARKET FOR AZOLES, BY DRUG TYPE, 2016-2023 ($MILLION)
TABLE 12. GLOBAL ANTIFUNGAL DRUGS MARKET FOR AZOLES, BY REGION, 2016-2023 ($MILLION)
TABLE 13. GLOBAL AZOLES ANTIFUNGAL DRUGS MARKET FOR IMIDAZOLES, BY REGION, 2016-2023 ($MILLION)
TABLE 14. GLOBAL AZOLES ANTIFUNGAL DRUGS MARKET FOR VORICANAZOLE, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL AZOLES ANTIFUNGAL DRUGS MARKET FOR THIAZOLES, BY REGION, 2016-2023 ($MILLION)
TABLE 16. GLOBAL AZOLES ANTIFUNGAL DRUGS MARKET FOR OTHER DRUGS, BY REGION, 2016-2023 ($MILLION)
TABLE 17. GLOBAL ANTIFUNGAL DRUGS MARKET FOR POLYENES, BY DRUG TYPE, 2016-2023 ($MILLION)
TABLE 18. GLOBAL ANTIFUNGAL DRUGS MARKET FOR POLYENES, BY REGION, 2016-2023 ($MILLION)
TABLE 19. GLOBAL POLYENES ANTIFUNGAL DRUGS MARKET FOR AMPHOTERICIN B, BY REGION, 2016-2023 ($MILLION)
TABLE 20. GLOBAL POLYENES ANTIFUNGAL DRUGS MARKET FOR CANDICIDIN, BY REGION, 2016-2023 ($MILLION)
TABLE 21. GLOBAL POLYENES ANTIFUNGAL DRUGS MARKET FOR HAMYCIN, BY REGION, 2016-2023 ($MILLION)
TABLE 22. GLOBAL POLYENES ANTIFUNGAL DRUGS MARKET FOR NATAMYCIN, BY REGION, 2016-2023 ($MILLION)
TABLE 23. GLOBAL POLYENES ANTIFUNGAL DRUGS MARKET FOR OTHER DRUGS, BY REGION, 2016-2023 ($MILLION)
TABLE 24. GLOBAL ANTIFUNGAL DRUGS FOR ALLYLAMINES MARKET, BY DRUG TYPE, 2016-2023 ($MILLION)
TABLE 25. GLOBAL ANTIFUNGAL DRUGS FOR ALLYLAMINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 26. GLOBAL ALLYLAMINES ANTIFUNGAL DRUGS MARKET FOR TERBINAFINE, BY REGION, 2016-2023 ($MILLION)
TABLE 27. GLOBAL ALLYLAMINES ANTIFUNGAL DRUGS MARKET FOR BUTENAFINE, BY REGION, 2016-2023 ($MILLION)
TABLE 28. GLOBAL ALLYLAMINES ANTIFUNGAL DRUGS MARKET FOR NAFTIFINE, BY REGION, 2016-2023 ($MILLION)
TABLE 29. GLOBAL ANTIFUNGAL DRUGS MARKET FOR OTHER, BY REGION, 2016-2023 ($MILLION)
TABLE 30. GLOBAL ANTIFUNGAL DRUGS MARKET, BY THERAPEUTIC INDICATIONS, 2016-2023 ($MILLION)
TABLE 31. GLOBAL ANTIFUNGAL DRUGS MARKET FOR ASPERGILLOSIS, BY REGION, 2016-2023 ($MILLION)
TABLE 32. GLOBAL ANTIFUNGAL DRUGS MARKET FOR DERMATOPHYTOSIS, BY REGION, 2016-2023 ($MILLION)
TABLE 33. GLOBAL ANTIFUNGAL DRUGS MARKET FOR CANDIDIASIS, BY REGION, 2016-2023 ($MILLION)
TABLE 34. GLOBAL ANTIFUNGAL DRUGS MARKET FOR THERAPEUTIC INDICATIONS BY REGION, 2016-2023 ($MILLION)
TABLE 35. GLOBAL ANTIFUNGAL DRUGS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 36. GLOBAL ANTIFUNGAL DRUGS MARKET FOR POWDER, BY REGION, 2016-2023 ($MILLION)
TABLE 37. GLOBAL ANTIFUNGAL DRUGS MARKET FOR OINTMENTS, BY REGION, 2016-2023 ($MILLION)
TABLE 38. GLOBAL ANTIFUNGAL DRUS MARKET FOR DRUGS, BY REGION, 2016-2023 ($MILLION)
TABLE 39. GLOBAL ANTIFUNGAL DRUGS MARKET FOR OTHER DOSAGE FORMS, BY REGION, 2016-2023 ($MILLION)
TABLE 40. GLOBAL ANTIFUNGAL DRUGS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 41. NORTH AMERICA ANTIFUNGAL DRUGS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 42. NORTH AMERICA ANTIFUNGAL DRUGS MARKET, BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 43. NORTH AMERICA ANTIFUNGAL DRUGS MARKET, BY DRUG TYPE, 2016-2023 ($MILLION)
TABLE 44. NORTH AMERICA ANTIFUNGAL DRUGS MARKET, BY THERAPEAUTIC INDICATION, 2016-2023 ($MILLION)
TABLE 45. NORTH AMERICA ANTIFUNGAL DRUGS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 46. EUROPE ANTIFUNGAL DRUGS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 47. EUROPE ANTIFUNGAL DRUGS MARKET, BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 48. EUROPE ANTIFUNGAL DRUGS MARKET, BY DRUG TYPE, 2016-2023 ($MILLION)
TABLE 49. EUROPE ANTIFUNGAL DRUGS MARKET, BY THERAPEAUTIC INDICATION, 2016-2023 ($MILLION)
TABLE 50. EUROPE ANTIFUNGAL DRUGS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 51. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 52. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET, BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 53. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET, BY DRUG TYPE, 2016-2023 ($MILLION)
TABLE 54. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET, BY THERAPEAUTIC INDICATION, 2016-2023 ($MILLION)
TABLE 55. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 56. LAMEA ANTIFUNGAL DRUGS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 57. LAMEA ANTIFUNGAL DRUGS MARKET, BY INFECTION TYPE, 2016-2023 ($MILLION)
TABLE 58. LAMEA ANTIFUNGAL DRUGS MARKET, BY DRUG TYPE, 2016-2023 ($MILLION)
TABLE 59. LAMEA ANTIFUNGAL DRUGS MARKET, BY THERAPEAUTIC INDICATION, 2016-2023 ($MILLION)
TABLE 60. LAMEA ANTIFUNGAL DRUGS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 61. PFIZER: COMPANY SNAPSHOT
TABLE 62. PFIZER: OPERATING SEGMENTS
TABLE 63. SANOFI: COMPANY SNAPSHOT
TABLE 64. SANOFI: OPERATING SEGMENTS
TABLE 65. GILEAD: COMPANY SNAPSHOT
TABLE 66. GILEAD: OPERATING SEGMENTS
TABLE 67. MERCK: COMPANY SNAPSHOT
TABLE 68. MERCK: OPERATING SEGMENTS
TABLE 69. NOVARTIS: COMPANY SNAPSHOT
TABLE 70. NOVARTIS: OPERATING SEGMENTS
TABLE 71. ABBOTT: COMPANY SNAPSHOT
TABLE 72. ABBOTT: OPERATING SEGMENTS
TABLE 73. BAYER: COMPANY SNAPSHOT
TABLE 74. BAYER: OPERATING SEGMENTS
TABLE 75. SCYNEXIS: COMPANY SNAPSHOT
TABLE 76. SCYNEXIS: OPERATING SEGMENTS
TABLE 77. ENZON: COMPANY SNAPSHOT
TABLE 78. ENZON: OPERATING SEGMENTS
TABLE 79. GSK: COMPANY SNAPSHOT
TABLE 80. GSK: OPERATING SEGMENTS

LIST OF FIGURE

FIGURE 1. GLOBAL ANTIFUNGAL DRUGS MARKET, 2016-2023
FIGURE 2. SEGMENTATION OF ANTIFUNGAL DRUGS MARKET
FIGURE 3. TOP INVESTMENT POCKETS IN GLOBAL ANTIFUNGAL DRUGS MARKET
FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2017)
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 7. BARGAINING POWER OF BUYERS
FIGURE 8. BARGAINING POWER OF SUPPLIERS
FIGURE 9. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. RESTRAINTS AND DRIVERS: GLOBAL ANTIFUNGAL DRUGS MARKET
FIGURE 13. U.S. ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 14. MEXICO ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 15. CANADA ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 16. UK ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 17. FRANCE ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 18. GERMANY ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 19. ITALY ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 20. SPAIN ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 21. REST OF EUROPE ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 22. JAPAN ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 23. CHINA ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 24. INDIA ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 25. AUSTRALIA ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 26. REST OF ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 27. BRAZIL ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 28. ARGENTINA ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 29. SAUDI ARABIA ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 30. SOUTH AFRICA ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 31. REST OF LAMEA ANTIFUNGAL DRUGS MARKET, 2016-2023 ($MILLION)
FIGURE 32. PFIZER: NET SALES, 2014-2016 ($MILLION)
FIGURE 33. PFIZER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 34. PFIZER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 35. SANOFI: NET SALES, 2014-2016 ($MILLION)
FIGURE 36. SANOFI: REVENUE BY SEGMENT, 2016 (%)
FIGURE 37. SANOFI: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 38. GILEAD: NET SALES, 2014-2016 ($MILLION)
FIGURE 39. GILEAD: REVENUE BY SEGMENT, 2016 (%)
FIGURE 40. GILEAD: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 41. MERCK: NET SALES, 2014-2016 ($MILLION)
FIGURE 42. MERCK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 43. MERCK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 44. NOVARTIS: NET SALES, 2014-2016 ($MILLION)
FIGURE 45. NOVARTIS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 46. NOVARTIS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 47. ABBOTT: NET SALES, 2014-2016 ($MILLION)
FIGURE 48. ABBOTT: REVENUE BY SEGMENT, 2016 (%)
FIGURE 49. ABBOTT: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 50. BAYER: NET SALES, 2014-2016 ($MILLION)
FIGURE 51. BAYER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 52. BAYER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 53. SCYNEXIS: NET SALES, 2014-2016 ($MILLION)
FIGURE 54. SCYNEXIS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 55. SCYNEXIS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 56. ENZON: NET SALES, 2014-2016 ($MILLION)
FIGURE 57. ENZON: REVENUE BY SEGMENT, 2016 (%)
FIGURE 58. ENZON: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 59. GSK: NET SALES, 2014-2016 ($MILLION)
FIGURE 60. GSK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 61. GSK: REVENUE BY GEOGRAPHY, 2016 (%)